Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monoclonal antibody EP-5C7

Drug Profile

Monoclonal antibody EP-5C7

Alternative Names: 5C7; Anti-E/P-selectin monoclonal antibody - Protein Design Labs; EP-5C7; HuEP5C7; HuEP5C7 MAb; Monoclonal antibody 5C7.29; SMART anti-E/P-selectin antibody

Latest Information Update: 14 May 2001

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator PDL BioPharma
  • Class Anti-inflammatories; Monoclonal antibodies
  • Mechanism of Action Selectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Autoimmune disorders; Psoriasis; Shock; Stroke

Most Recent Events

  • 14 May 2001 Discontinued-I for Asthma in USA (Unknown route)
  • 14 May 2001 Discontinued-I for Autoimmune disorders in USA (Unknown route)
  • 14 May 2001 Discontinued-I for Psoriasis in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top